The Skeletal L-type Ca2+ Current Is a Major Contributor to Excitation-coupled Ca2+ entry by Bannister, Roger A. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
G
e
n
e
r
a
l
 
P
h
y
s
i
o
l
o
g
y
ARTICLE
The Rockefeller University Press  $30.00
J. Gen. Physiol. Vol. 133 No. 1  79–91
www.jgp.org/cgi/doi/10.1085/jgp.200810105 79
        INTRODUCTION  
  The skeletal muscle L-type Ca 
2+   channel (1,4-dihydro-
pyridine receptor [DHPR]) serves as the voltage sensor 
for excitation  –  contraction (EC) coupling (  Tanabe et al., 
1988  ). Conformational changes in the DHPR in re-
sponse to membrane depolarization are coupled to gat-
ing of the type 1 RYR (RYR1) of the SR (  Beam and 
Horowicz, 2004  ). The resultant Ca 
2+   effl  ux via RYR1 
into the myoplasm initiates contraction (  Beam and 
Horowicz, 2004  ). It has also been reported that the in-
teraction between the DHPR and RYR1 activates entry 
of extracellular Ca 
2+   into the myoplasm via an as yet un-
identifi  ed pathway (  Cherednichenko et al., 2004, 2008  ; 
  Hurne et al., 2005  ;   Yang et al., 2007  ;   Gach et al., 2008  ; 
  Lyfenko and Dirksen, 2008  ). This form of Ca 
2+   entry, 
termed excitation-coupled Ca 
2+   entry (ECCE), requires 
expression of both the DHPR and RYR1, as ECCE is ab-
sent in dysgenic (DHPR       1S   subunit  –  null) and dyspedic 
(RYR1-null) myotubes, respectively.   Cherednichenko 
et al. (2004)   proposed that ECCE is independent of L-type 
Ca 
2+   current via the DHPR because ECCE (as assessed 
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  Abbreviations used in this paper: 2-APB, 2-aminoethyl diphenylborate; 
DHPR, 1,4-dihydropyridine receptor; EC, excitation  –  contraction; ECCE, 
excitation-coupled Ca 
2+   entry; SOCE, store-operated Ca 
2+   entry.   
by Mn 
2+   quench of the ratiometric Ca 
2+   indicator Fura-2) 
persists in dysgenic myotubes transfected with an       1S   
pore mutant (SkEIIIK) thought to conduct only mon-
ovalent cations (  Dirksen and Beam, 1999  ). Thus, it was 
proposed that ECCE involved an as yet unidentifi  ed 
channel activated by conformational coupling to both 
the DHPR and RYR1. 
  When myotubes are stimulated either by maintained 
depolarization with KCl or by repetitive, brief electri-
cal stimuli, myoplasmic Ca 
2+   levels initially rise and 
then decay as a consequence of declining release from 
the SR, although this decay is slowed by the entry of 
external Ca 
2+   associated with ECCE (  Yang et al., 2007  ; 
  Cherednichenko et al., 2008  ;   Gach et al., 2008  ). Fur-
thermore, ECCE is accentuated in myotubes express-
ing RYR1 constructs that carry mutations causing 
malignant hyperthermia in humans (  Yang et al., 2007  ; 
  Cherednichenko et al., 2008  ). Thus, it appears that 
ECCE may be important in normal skeletal muscle for 
helping to maintain force generation during tetanic 
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          The term excitation-coupled Ca 
2+   entry (ECCE) designates the entry of extracellular Ca 
2+   into skeletal muscle 
cells, which occurs in response to prolonged depolarization or pulse trains and depends on the presence of both 
the 1,4-dihydropyridine receptor (DHPR) in the plasma membrane and the type 1 ryanodine receptor in the sar-
coplasmic reticulum (SR) membrane. The ECCE pathway is blocked by pharmacological agents that also block 
store-operated Ca 
2+   entry, is inhibited by dantrolene, is relatively insensitive to the DHP antagonist nifedipine 
(1   μ  M), and is permeable to Mn 
2+  . Here, we have examined the effects of these agents on the L-type Ca 
2+   current 
conducted via the DHPR. We found that the nonspecifi  c cation channel antagonists (2-APB, SKF 96356, La 
3+  , and 
Gd 
3+  ) and dantrolene all inhibited the L-type Ca 
2+   current. In addition, complete (  >  97%) block of the L-type cur-
rent required concentrations of nifedipine   >  10   μ  M. Like ECCE, the L-type Ca 
2+   channel displays permeability to 
Mn 
2+   in the absence of external Ca 
2+   and produces a Ca 
2+   current that persists during prolonged (    10-second) de-
polarization. This current appears to contribute to the Ca 
2+   transient observed during prolonged KCl depolariza-
tion of intact myotubes because (1) the transients in normal myotubes decayed more rapidly in the absence of 
external Ca 
2+  ; (2) the transients in dysgenic myotubes expressing SkEIIIK (a DHPR       1S   pore mutant thought to 
conduct only monovalent cations) had a time course like that of normal myotubes in Ca 
2+  -free solution and were 
unaffected by Ca 
2+   removal; and (3) after block of SR Ca 
2+   release by 200   μ  M ryanodine, normal myotubes still 
displayed a large Ca 
2+   transient, whereas no transient was detectable in SkEIIIK-expressing dysgenic myotubes. 
Collectively, these results indicate that the skeletal muscle L-type channel is a major contributor to the Ca 
2+   entry 
attributed to ECCE. 
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  MATERIALS AND METHODS  
  Myotube Culture and cDNA Expression 
  All procedures involving mice were approved by the University 
of Colorado Denver Institutional Animal Care and Use Com-
mittee. Primary cultures of normal (+/+ or +/  mdg  ), dysgenic 
(  mdg  /  mdg  ), dyspedic (RYR1 
     /RYR1 
     ), and       1  -null (      1   
     /      1   
     ) 
myotubes were prepared as described previously (  Beam and 
Franzini-Armstrong, 1997  ). Cultures were grown for 6  –  7 d in a 
humidifi  ed 37  °  C incubator with 5% CO  2   in Dulbecco  ’  s modifi  ed 
Eagle  ’  s medium (DMEM; Mediatech), supplemented with 10% 
fetal bovine serum/10% horse serum (Hyclone Laboratories). 
This medium was then replaced with differentiation medium 
(DMEM supplemented with 2% horse serum). In experiments 
that required exogenous expression of SkEIIIK in dysgenic 
myotubes, single nuclei were microinjected with a solution of 
plasmid cDNA encoding SkEIIIK (400 ng/  μ  l) (  Dirksen and 
Beam, 1999  ) and either pEYFP-C1 or pDsRed2-C1 (10 ng/  μ  l; 
both from Clontech) 2 d after the switch to differentiation me-
dium. Fluorescent myotubes were used in experiments 2 d after 
microinjection. 
  Measurement of L-type Ca 
2+   Currents 
  Pipettes were fabricated from borosilicate glass and had resis-
tances of     1.5 M  Ω   when fi  lled with internal solution, which con-
sisted of (in mM): 140 Cs-aspartate, 10 Cs  2  -EGTA, 5 MgCl  2  , and 
10 HEPES, pH 7.4, with CsOH. The standard external solution 
contained (in mM): 145 TEA-Cl, 10 CaCl  2  , 0.003 tetrodotoxin, 
and 10 HEPES, pH 7.4, with TEA-OH. In some experiments, 
2 mM CaCl  2  , 10 mM MnCl  2  , or 0.5 mM MnCl  2   was substituted for 
10 mM CaCl  2  . For generation of I-V relationships, linear capaci-
tive and leakage currents were determined by averaging the cur-
rents elicited by 11 30-mV hyperpolarizing pulses from the 
holding potential of     80 mV. Test currents were corrected for 
linear components of leak and capacitive current by digital scal-
ing and subtraction of this average control current. In all other 
experiments,     P/4 subtraction was used. Electronic compensa-
tion was used to reduce the effective series resistance (usually to 
  <  1 M  Ω  ) and the time constant for charging the linear cell capaci-
tance (usually to   <  0.5 ms). L-type currents were fi  ltered at 2 kHz 
and digitized at 5  –  10 kHz. In most cases, a 1-s prepulse to     20 mV 
followed by a 50-ms repolarization to     50 mV was administered 
before the test pulse (prepulse protocol; see   Adams et al., 1990  ) 
to inactivate T-type Ca 
2+   channels. Cell capacitance was deter-
mined by integration of a transient from     80 to     70 mV using 
Clampex 8.0 (MDS Analytical Technologies) and was used to nor-
malize current amplitudes (pA/pF). I-V curves were fi  tted using 
the following equation: 
     I = G * (V   V ) / {1 + exp[ (V   V ) / k ]}, max rev 1/2 G -- -      (1) 
  where I is the peak current for the test potential V, V  rev   is the re-
versal potential, G  max   is the maximum Ca 
2+   channel conduc-
tance, V  1/2   is the half-maximal activation potential, and k  G   is the 
slope factor. The deactivation phase of SkEIIIK tail currents was 
fi  tted as: 
     I(t) = A [exp( t/ )] + C, -t      (2) 
  where I(t) is the current at time t after the repolarization, A is the 
peak tail current amplitude,      is the deactivation time constant, 
and C represents the steady current (see   Wilkens et al., 2001  ). All 
electrophysiological experiments were performed at room tem-
perature (    25  °  C). 
stimulation, and that accentuated ECCE may contribute 
to the pathophysiological increase in myoplasmic Ca 
2+   
that occurs during episodes of malignant hyperthermia. 
  ECCE is blocked by 2-aminoethyl diphenylborate 
(2-APB), SKF 96356, La 
3+  , and Gd 
3+   (  Cherednichenko 
et al., 2004  ;   Hurne et al., 2005  ) and thus has a pharma-
co  logical profi  le similar to that of store-operated Ca 
2+   
entry (SOCE) and transient receptor potential  –  like 
chan  nels. However, ECCE can occur without any store 
depletion (  Cherednichenko et al., 2004, 2008  ;   Hurne 
et al., 2005  ;   Yang et al., 2007  ;   Gach et al., 2008  ;   Lyfenko 
and Dirksen, 2008  ) or in cells in which stores are fully 
depleted (  Cherednichenko et al., 2004  ;   Gach et al., 
2008  ). Furthermore, all attempts to identify transient 
receptor potential or SOCE channels as the molecular 
basis of ECCE have failed (  Lee et al., 2006  ;   Lyfenko and 
Dirksen, 2008  ;   Woo et al., 2008  ). 
  While attempting to identify the Ca 
2+   current associ-
ated with ECCE, we noticed that 2-APB, SKF 96356, La 
3+  , 
and Gd 
3+   each block the skeletal muscle L-type current, 
as has been reported for ECCE (  Cherednichenko et al., 
2004  ;   Hurne et al., 2005  ;   Yang et al., 2007  ). These re-
sults prompted us to reexamine the similarities and dif-
ferences between the skeletal muscle L-type current 
and ECCE. We found that the L-type current is incom-
pletely (    50%) blocked by 1   μ  M nifedipine and par-
tially inhibited by the anti-malignant hyperthermia drug 
dantrolene, as described previously for ECCE (  Yang et al., 
2007  ;   Cherednichenko et al., 2008  ). Also like ECCE 
(  Cherednichenko et al., 2004, 2008  ;   Hurne et al., 2005  ; 
  Gach et al., 2008  ;   Lyfenko and Dirksen, 2008  ), we found 
that the L-type channel can conduct Mn 
2+   in the ab-
sence of external Ca 
2+  . 
  In addition to examining the pharmacology of the 
DHPR, we evaluated the contribution of the L-type cur-
rent to myoplasmic Ca 
2+   transients. In normal myotubes, 
the Ca 
2+   transient decays during maintained depolariza-
tion due to inactivation of EC coupling (  Beam and 
Horowicz, 2004  ). This decay is accelerated by the re-
moval of external Ca 
2+   or by the addition of Gd 
3+  , consis-
tent with the idea that Ca 
2+   entry contributes to the 
transient (  Cherednichenko et al., 2004  ;   Yang et al., 
2007  ). In the present study, a substantial contribution of 
L-type current to this entry was revealed by the observa-
tion that the decay of the myoplamsic Ca 
2+   transient in 
dysgenic cells expressing SkEIIIK was essentially un-
changed by the removal of extracellular Ca 
2+   and resem-
bled that of normal myotubes in the absence of external 
Ca 
2+   or in the presence of Gd 
3+  . Furthermore, when in-
tracellular Ca 
2+   release was blocked by ryanodine, no 
Ca 
2+   transients were detectable in SkEIIIK-expressing 
dysgenic myotubes. Collectively, our results indicate that 
the skeletal muscle L-type Ca 
2+   current is a major con-
tributor to the Ca 
2+   entry that occurs during depolariza-
tion of myotubes.     Bannister et al.  81
tical comparisons were by ANOVA or by unpaired two-tailed   t   test 
(as appropriate), with P   <   0.05 considered signifi  cant. 
  Online Supplemental Material 
  Fig. S1 shows that SKF 96356 accelerated the inactivation ki-
netics of the L-type current suffi  ciently so that block was essen-
tially complete at test pulses slightly longer than the test pulse 
shown in   Fig. 1 D  . Fig. S2 shows the I-V relationships for dysgenic 
myotubes expressing SkEIIIK in the presence and absence of 
5   μ  M   ±   Bay K 8644. Fig. S3 shows that the anti-malignant hyper-
thermia drug dantrolene partially inhibits Ca 
2+   entry during long 
  Ca 
2+   Imaging 
  Myotubes were washed with Ca 
2+  /Mg 
2+  -free Ringer  ’  s solution (in 
mM: 146 NaCl, 5 KCl, 10 HEPES, and 11 glucose, pH 7.4, with 
NaOH) twice and loaded with 5   μ  M Fluo-3-AM (Invitrogen) dis-
solved in Rodent Ringer  ’  s solution (in mM: 146 NaCl, 5 KCl, 
2 CaCl  2  , 1 MgCl  2  , and 10 HEPES, pH 7.4, with NaOH) for 20 min. 
Myotubes were then washed three times in Rodent Ringer  ’  s solu-
tion with gentle agitation. Fluo-3-AM  –  loaded myotubes bathed in 
either Rodent Ringer  ’  s solution or 0 Ca 
2+   Rodent Ringer  ’  s solu-
tion (in mM: 146 NaCl, 5 KCl, 3 MgSO  4  , and 10 HEPES, pH 7.4, 
with NaOH) were then placed on the stage of an LSM META 
scanning laser confocal microscope (Carl Zeiss, Inc.) and viewed 
under either 10 or 40  ×   magnifi  cation. 10  –  100   μ  M   N  -benzyl-  p  -tolu-
ensulfonamide (Sigma-Aldrich) was continuously present in the 
bath solution (    25  °  C) to prevent myotube contractions. Fluo-3 
was excited with the 488-nm line of an argon laser (30-milliwatt 
maximum output, operated at 50% or 6.3A, attenuated to 1  –  2%). 
The emitted fl   uorescence was directed to a photomultiplier 
equipped with either a 505-nm long-pass fi  lter or a 505  –  530-nm 
band-pass fi  lter. Confocal fl  uorescence intensity data were digi-
tized at 8 bits, with the photomultiplier gain and offset adjusted 
such that maximum pixel intensities were no more than     70% 
saturated and cell-free areas had close to zero intensity. Myoplas-
mic Ca 
2+   transients were elicited by application of high KCl Ring-
er  ’  s solution (in mM: 71 NaCl, 80 KCl, 2 CaCl  2  , 1 MgCl  2  , and 10 
HEPES, pH 7.4, with NaOH) or 0 Ca 
2+  /high KCl Ringer  ’  s solution 
(in mM: 71 NaCl, 80 KCl, 3 MgSO  4  , and 10 HEPES, pH 7.4, with 
NaOH) via an extracellular pipette placed near the myotube of 
interest or a manually operated, gravity-driven global perfusion 
system that produced complete exchange within     5 s. Although 
slower, the latter method had the advantage of producing an ex-
posure to high KCl that was more uniform for entire myotubes 
and allowed the sampling of responses from many myotubes si-
multaneously, which was especially useful for myotubes express-
ing the SkEIIIK construct. Fluorescence amplitude data are 
expressed as     F/F, where F represents the baseline fl  uorescence 
before the application of high KCl Ringer  ’  s solution, and     F rep-
resents the change in peak fl  uorescence during the application of 
high KCl Ringer  ’  s solution. In addition to peak     F/F, the follow-
ing parameters were assessed: (1) t  peak   = [time at peak     F]      [time 
at onset of the upswing of the transient], (2) t  1/2     decay   = time of de-
cay from peak to 50% of peak     F/2, and (3) r  20   = [    F at the end 
of a 20-s KCl depolarization]/[peak     F]   ×   100. 
  Pharmacology 
  Ryanodine (Sigma-Aldrich) was reconstituted in 40% EtOH and 
diluted to 200   μ  M in differentiation medium. GdCl  3   (Sigma-
Aldrich) or LaCl  3   (Sigma-Aldrich) was dissolved in water to make 
0.1-M stock solutions and was then added to standard external re-
cording solution for a fi  nal trivalent cation concentration of 
100   μ  M. 2-APB (Sigma-Aldrich) and SKF 96356 (provided by O. 
Delbono, Wake Forest University, Winston-Salem, NC) were dis-
solved in DMSO (Sigma-Aldrich) to make 1-M and 50-mM stock 
solutions, respectively. Nifedipine (EMD) was dissolved in 50% 
EtOH and diluted to various concentrations just before experiments. 
In some experiments, Ca 
2+   currents were recorded in the continuous 
presence of 5   μ  M of racemic Bay K 8644 (provided by A. Scriabine, 
Miles Laboratories Inc., New Haven, CT) in the bath solution. 
Racemic Bay K 8644 was stored as a 20-mM stock in 50% EtOH. 
Dantrolene (Sigma-Aldrich) was dissolved in dry DMSO to make a 
20-mM stock solution and diluted to 10   μ  M just before use. Dihy-
dropyridines, 2-APB, SKF 96356, and dantrolene were stored and 
used in the dark. 
  Analysis 
  Figures were made using the software program SigmaPlot (ver-
sion 7.0; SSPS Inc.). All data are presented as mean   ±   SEM. Statis-
  Figure 1.     Skeletal muscle L-type current is blocked by nonspe-
cifi  c cation channel antagonists. Acute block of L-type currents 
evoked by step depolarizations to +30 mV by 100   μ  M Gd 
3+   (A), 
100   μ  M La 
3+   (B), 100   μ  M 2-APB (C), and 20   μ  M SKF 96356 (D). 
The test pulse was applied after a prepulse protocol (see Materials 
and methods) (  Adams et al., 1990  ). Results of these experiments 
and application of DMSO vehicle (0.01%) control experiments 
are summarized in E. For trivalent cations, maximal block was 
generally achieved in   <  30 s after gravity perfusion of the 30-mm 
dish, whereas longer perfusion times were required for maximal 
block by 2-APB (1  –  2 min) and SKF 96356 (2  –  3 min). The asterisk 
indicates a signifi  cant difference for current (measured at the end 
of a 200-ms test pulse) remaining in myotubes exposed to block-
ers relative to DMSO-treated control cells (P   <   0.0001, ANOVA). 
Although not indicated, block by SKF 96356 measured at the end 
of a 500-ms test pulse was also signifi  cantly (P   <   0.00008,   t   test) 
different than DMSO controls. Throughout, the error bars rep-
resent   ±   SEM.     82   The Skeletal L-type Current Contributes to ECCE 
the inactivation kinetics of the L-type current suffi  ciently 
so that block was essentially complete (98   ±   2% block; 
  n   = 3) at 500 ms (Fig. S1). The L-type current was not ap-
preciably affected by exposure to DMSO vehicle (7   ±   
5%;   n   = 3; P   <   0.0001, ANOVA;   Fig. 1 E  ). 
  Complete Block of Skeletal L-type Current Requires a High 
Concentration of Nifedipine 
  A small component of ECCE is blocked by the 1,4-dihy-
dropyridine L-type Ca 
2+   channel antagonist, nifedipine 
(1   μ  M) (  Yang et al., 2007  ), whereas ECCE is completely 
blocked by 50   μ  M nifedipine (see   Fig. 7 C  ). Block of 
the L-type current showed a similar dependence on 
nifedipine dose; only partial block was produced by ei-
ther 1 or 10   μ  M nifedipine (  Fig. 2, A and B  ), whereas 
nearly complete block required 50   μ  M nifedipine (  Fig. 
2 C  ).   The dose  –  response curve for nifedipine is shown 
in   Fig. 2 D  . 
exposures to elevated KCl. Figs. S1  –  S3 are available at http://
www.jgp.org/cgi/content/full/jgp.200810105/DC1. 
  RESULTS  
  L-type Current Is Blocked by Nonspeciﬁ  c Cation 
Channel Blockers 
  ECCE can be blocked by exposure to trivalent metal ions 
(Gd 
3+   and La 
3+  ) and to the nonspecifi  c cation channel 
blockers 2-APB and SKF 96356 (  Cherednichenko et al., 
2004 ;   Hurne et al., 2005  ;   Yang et al., 2007  ).   Fig. 1 (A and B) 
 shows that Gd 
3+   and La 
3+   (both 100   μ  M) potently blocked 
the skeletal L-type current by 96   ±   1% (  n   = 7) and 97   ±   
1% (  n   = 4), respectively.   Substantial block of the L-type 
current was also produced by exposure of normal myo-
tubes to 100   μ  M 2-APB (87   ±   2%;   n   = 6;   Fig. 1 C  ) and to 
20   μ  M SKF 96356 (at the end of 200-ms test pulses: 81   ±   
3%;   n   = 4;   Fig. 1 D  ). Moreover, SKF 96356 accelerated 
  Figure 2.     Block of skeletal L-type current by nife-
dipine. (A) Incomplete block of L-type current by 
1   μ  M nifedipine. (B) Incomplete block of L-type 
current by 10   μ  M nifedipine. (C) Complete block of 
L-type current by 50   μ  M nifedipine. Currents evoked 
by step depolarizations to +30 mV from     50 mV 
after a prepulse protocol (see Materials and meth-
ods). (D) Dose  –  response relationship for the effects 
of nifedipine, which were measured     1 min after 
addition. Note that the minimal apparent block (at 
1 nM) was     80%, most likely as a consequence of 
current rundown. Each symbol represents data col-
lected from 2  –  10 cells.     
  TABLE I  
  Conductance Fits 
G-V
  G  max 
     (nS/nF)
  V    1/2 
   (mV)
  k  G 
     (mV)
normal (10 mM Ca 
2+   external) 244   ±   12 
  (10)
18.1   ±   1.4 4.4   ±   0.2
normal (2 mM Ca 
2+   external) 115   ±   16   
a     
  (4)
7.8   ±   2.4   
b   4.7    ±   0.5
normal (10 mM Ca 
2+   external)
    + 10   μ  M dantrolene
228   ±   10 
  (12)
22.4   ±   0.8   
b   5.2    ±   0.2   
b   
normal (10 mM Mn 
2+   external) 135   ±   6   
b     
  (4)
16.7   ±   1.9 5.6   ±   0.2   
b   
Data are given as mean   ±   SEM, with the numbers in parentheses indicating the number of myotubes tested. Data were fi  t according to Eq. 1 (see Materials 
and Methods). Asterisks indicate signifi  cant differences compared to L-type currents recorded from normal, untreated myotubes in 10 mM external Ca 
2+ 
   
a    P   <   10 
    4  ,   t   test.
   
b    P   <   0.01,   t   test.    Bannister et al.  83
  L-type Channels Inactivate Slowly and Conduct Substantial 
Current at Weak Test Potentials in Physiological Ca 
2+   
  The pharmacological data described above were ob-
tained using 200-ms test pulses and 10 mM Ca 
2+   in the ex-
ternal recording solution to allow comparison with 
previous data from our laboratory. Under these condi-
tions, no L-type current was observable at test potentials 
below +10 mV. In contrast, ECCE can be strongly evoked 
by     80 mM KCl (  Hurne et al., 2005  ), which results in de-
polarizations to between     10 and 0 mV (Allen, P.D., and 
J.R. L  ó  pez, personal communication). To determine 
whether L-type current can be observed in the same range 
of potentials as ECCE, we reduced the external Ca 
2+   to 
the more physiological 2 mM used for the ECCE mea-
surements (  Cherednichenko et al., 2004, 2008  ;   Hurne 
et al., 2005  ;   Yang et al., 2007  ;   Gach et al., 2008  ;   Lyfenko 
and Dirksen, 2008  ). This maneuver reduced L-type cur-
rent amplitude and caused an     11-mV hyperpolarizing 
shift in the peak I-V relationship measured with 200-ms 
test pulses (P = 0.0011;   Fig. 4 A   and   Table I  ).   However, the 
currents were much larger with     10-s depolarizations 
  Dantrolene Inhibits L-type Currents 
  The anti-malignant hyperthermia drug dantrolene at 
10   μ  M blocks     65% of ECCE as measured by Mn 
2+   
quench (  Cherednichenko et al., 2008  ). We found that 
10   μ  M dantrolene also inhibited the L-type current in 
myotubes (  Fig. 3   and   Table I  ).   At +30 mV (near the peak 
of the I-V relationship), dantrolene inhibited L-type cur-
rent by     19% compared with untreated control myo-
tubes (    9.7   ±   0.6 pA/pF;   n   = 12 vs.     11.9   ±   0.5 pA/pF; 
  n   = 10, respectively; P   <   0.05).   Dantrolene also caused 
an     5-mV depolarizing shift in the I-V relationship 
(  Fig. 3 C  ). Collectively, the data presented in   Figs. 1  –  3   
indicate that the skeletal L-type Ca 
2+   current and ECCE 
have very similar pharmacological profi  les. 
  Figure 3.     Dantrolene inhibits skeletal L-type Ca 
2+   currents. Re-
cordings of L-type currents elicited by 200-ms depolarizations 
from     50 mV to the indicated test potentials are shown for an 
untreated normal myotube (A) or a normal myotube exposed to 
10   μ  M dantrolene for   >  10 min at     25  °  C (B). (C) Comparison 
of I-V relationships for untreated (    ;   n   = 10) and dantrolene-
treated myotubes (    ;   n   = 12). Currents were evoked at 0.1 Hz in 
10-mV increments after a prepulse protocol (see Materials and 
methods). Current amplitudes were normalized by linear cell ca-
pacitance (pA/pF). The smooth curves are plotted according to 
Eq. 1, with best-fi  t parameters presented in   Table I  .     
  Figure 4.     In 2 mM of external Ca 
2+  , L-type currents are activated 
by weak depolarizations and inactivate very slowly. (A) Compari-
son of I-V relationships for normal myotubes in 10 mM of exter-
nal Ca 
2+   (    ;   n   = 10) or 2 mM of external Ca 
2+   (    ;   n   = 4) elicited 
at 0.1 Hz by test potentials ranging from     20 through +80 mV in 
10-mV increments after a prepulse protocol. The smooth curves 
are plotted according to Eq. 1. The best-fi  t parameters for each 
plot are presented in   Table I  . (B) Recordings of L-type currents in 
2 mM of external Ca 
2+   elicited by 9,800-ms depolarizations from 
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external Ca 
2+  ), large L-type Ca 
2+   currents were observed 
at depolarizations to +30 mV (  Fig. 5 B  , bottom trace). 
A substantial current remained upon the replacement 
of 10 mM Ca 
2+   by 10 mM Mn 
2+   (  Fig. 5 B  , middle trace). 
This Mn 
2+   current was blocked nearly completely by 10   μ  M 
nifedipine (95   ±   2% channel block;   n   = 4), confi  rming 
that the Mn 
2+   entry was indeed via L-type channels 
(  Fig. 5 B  , top trace). 
  To approximate the conditions that have been previ-
ously used to measure ECCE via Mn 
2+   quench, we also 
recorded L-type currents in the presence of 0.5 mM Mn 
2+   
(  Fig. 5 C  ). Under these conditions, the average current 
amplitude was reduced (  Fig. 5 D  ), and there was a sub-
stantial hyperpolarizing shift in the activation of the Mn 
2+   
current (i.e., peaking at     0 mV;   Fig. 5, C and D  ). 
  Ca 
2+   Inﬂ  ux via the L-type Channel Accounts 
for the Majority of Ca 
2+   Inﬂ  ux in Response 
to Extended Depolarization 
    Cherednichenko et al. (2004)   found that ECCE could 
be detected in dysgenic myotubes after the expression 
like those used to elicit ECCE (  Cherednichenko et al., 
2004  ;   Hurne et al., 2005  ) because activation was so slow 
(  Fig. 4 B  ). In particular, L-type currents evoked at     10 mV 
in 2 mM Ca 
2+   had a time-to-peak of 4.02   ±   1.02 s (  n   = 6; 
  Table II  ).   Furthermore, the current inactivated very 
little under these conditions (36% in 9 s;   Table II  ). Col-
lectively, the data in   Fig. 4   indicate that long, weak depo-
larizations elicit substantial, sustained L-type current in 
the presence of physiological Ca 
2+  . 
  Skeletal Muscle L-type Channels Pass Mn 
2+   
  In addition to producing Ca 
2+   entry measurable as a 
component of myoplasmic Ca 
2+   transients (compare 
with   Yang et al., 2007  ), ECCE can be assayed by quench 
of Fura-2 fl  uorescence resulting from Mn 
2+   infl  ux in the 
absence of extracellular Ca 
2+   (  Cherednichenko et al., 
2004, 2008  ;   Hurne et al., 2005  ;   Gach et al., 2008  ; 
  Lyfenko and Dirksen, 2008 ).  Fig. 5 A  shows that the L-type 
channel also conducts Mn 
2+   ions in the absence of ex-
ternal Ca 
2+   (peak current of     4.1   ±   0.3 pA/pF at +30 
mV;   n   = 4).   Under standard recording conditions (10 mM 
  TABLE II  
  Activation and Decay of L-type Current during Extended Depolarizations 
I  peak   
  (pA/pF)
t  peak   
  (s)
t  1/2decay   
  (s)
r  9   
  (%)
normal (    10 mV)     0.7   ±   0.2 
  (5)
4.02   ±   1.02 
  (6)
ND 0.64   ±   0.10 
  (6)
normal (0 mV)     2.3   ±   0.6 
  (5)
2.54   ±   1.14 
  (6)
2.65   ±   0.34 
  (6)
0.52   ±   0.10 
  (6)
Data presented here were obtained from 9.8-s test potentials from     80 to     10 and 0 mV with 2 mM Ca 
2+   in the external recording solution. r  9   is ratio of 
the current remaining at 9 s to the peak current. t  1/2     decay   at     10 mV was not determined (ND) because the test potential was too short to accurately assess 
this parameter in three of six cells. Data are given as mean   ±   SEM, with the numbers in parentheses indicating the number of myotubes tested.
  Figure 5.     The skeletal muscle L-type channel 
conducts Mn 
2+  . (A) I-V relationship for nor-
mal myotubes in 10 mM of external Mn 
2+   (    ; 
  n   = 4) for currents elicited at 0.1 Hz by test 
potentials ranging from     20 through +80 mV 
in 10-mV increments after a prepulse proto-
col. The smooth curves are plotted according 
to Eq. 1. The best-fi  t parameters for each plot 
are presented in   Table I  . (B) Representative 
currents recorded at +30 mV from a normal 
myotube in 10 mM Ca 
2+   (bottom trace), in 
10 mM Mn 
2+   (middle trace), and in 10 mM 
Mn 
2+   after acute application of 10   μ  M nife-
dipine (top trace). (C) L-type current evoked 
by steps from     50 to 0 mV (top) and to +30 
mV (bottom) in 0.5 mM Mn 
2+  . (D) Average 
peak currents in 10 mM of divalent cation at a 
test potential of +30 mV (left) and for 0.5 mM 
Mn 
2+   at the indicated test potentials (right).         Bannister et al.  85
  In 2 mM Ca 
2+  , high KCl-evoked Ca 
2+   transients of dys-
genic myotubes expressing SkEIIIK also decayed more 
rapidly than Ca 
2+   transients of normal myotubes ( Fig. 6 C ), 
having decay kinetics (t  1/2     decay   = 4.47   ±   0.52 s; r  20   = 10.41   ±   
2.70 s;   n   = 9;   Fig. 6, E and F  ) more similar to those of 
normal myotubes in nominally 0 mM Ca 
2+   than in 2 mM 
Ca 
2+   (  Table III  ). Furthermore, the decay kinetics of Ca 
2+   
transients in myotubes expressing SkEIIIK were little af-
fected by the removal of extracellular Ca 
2+   (t  1/2     decay   = 
5.68   ±   1.16 s; r  20   = 4.97  ±   2.17%;   n   = 5;   Fig. 6, D  –  F , and 
  Table III  ). The fact that Ca 
2+   removal accelerated the 
decay of Ca 
2+   transients in normal myotubes but not in 
dysgenic myotubes expressing SkEIIIK is consistent with 
the idea that Ca 
2+   entry slows the decay of transients in 
normal myotubes bathed in 2 mM Ca 
2+  , and that this 
entry does not occur for SkEIIIK. 
  In control experiments, untransfected dysgenic and 
dyspedic myotubes failed to respond to locally applied 
80 mM KCl (  n   = 12 and 14, respectively;   Table III  ). Myo-
tubes harvested from mice null for the DHPR       1   sub-
unit also failed to respond to locally applied 80 mM KCl 
Ringer  ’  s solution (  n   = 10;   Table III  ). 
  SkEIIIK Supports Minimal Ca 
2+   Entry during Long, 
Global Depolarizations 
  To assess changes in myoplasmic Ca 
2+   attributable solely 
to Ca 
2+   infl  ux, we applied 80 mM KCl globally to myo-
tubes after block of intracellular Ca 
2+   release by ryano-
dine pretreatment (200   μ  M;   >   1 h; 37  °  C). Under these 
of a DHPR       1S   subunit in which a conserved glutamate 
in the pore-forming region of repeat III was mutated to 
lysine (SkEIIIK) (  Dirksen and Beam, 1999  ). Because 
SkEIIIK produces no obvious inward Ca 
2+   current dur-
ing 200-ms depolarizations or subsequent repolariza-
tion (  Dirksen and Beam, 1999  ) (Fig. S2), it was 
concluded that ECCE was independent of cation fl  ux 
via the L-type channel. To assess a potential contribu-
tion of the L-type current to ECCE, we compared myo-
plasmic Ca 
2+   transients that were elicited locally by 20-s 
exposures to elevated (80 mM) KCl in both untrans-
fected normal myotubes and dysgenic myotubes ex-
pressing SkEIIIK. Ca 
2+   transients of normal myotubes 
elicited by locally applied 80 mM KCl (  Fig. 6 A  ) rose to 
a peak and decayed slowly (t  1/2     decay   = 10.64   ±   0.98 s;   n   = 
24) and incompletely (r  20   = 31.92   ±   5.03%).   As shown 
in   Fig. 6 B  , transients of normal myotubes obtained 
in nominally 0 mM Ca 
2+   decayed much faster (t  1/2     decay   = 
4.98   ±   0.45 s;   n   = 12; P   <   0.0005,   t   test) and more com-
pletely (r  20   = 4.36   ±   2.38%; P   <   0.001,   t   test) than tran-
sients measured in 2 mM Ca 
2+   ( Fig. 6, B –  D  , superimp osed 
gray trace). An accelerated rate of decay was also 
observed in experiments in which 100   μ  M Gd 
3+   was 
added to the 80 KCl Ringer  ’  s solution in the micro-
pipette (t  1/2     decay   = 3.49   ±   0.47 s; r  20   = 2.23   ±   0.74%;   n   = 14; 
  Table III  ), supporting the idea that the acceleration of 
decay in 0 mM Ca 
2+   resulted from a loss of Ca 
2+   entry 
rather than from some other effect of removing Ca 
2+   
from the bath.   
  Figure 6.     Ca 
2+   infl  ux via the L-type channel accounts for 
the bulk of Ca 
2+   infl  ux in response to depolarization. Rep-
resentative Ca 
2+   transients are shown for a normal myotube 
in 2 mM of bath Ca 
2+   (A), a normal myotube in nominal 
0 mM of bath Ca 
2+   (B), a dysgenic myotube expressing 
SkEIIIK in 2 mM Ca 
2+   (C), and a dysgenic myotube ex-
pressing SkEIIIK in 0 mM Ca 
2+   (D). Summary of t  1/2     decay   
(E) and r  20   (F) values for normal myotubes and dysgenic 
myotubes expressing SkEIIIK in the presence (solid bars) 
and absence (hatched bars) of 2 mM Ca 
2+  . In B  –  D, a scaled 
version of the transient shown in A has been included for 
comparison of the rates of transient decay (gray traces). 
Transients were elicited locally by 20-s applications of 
80 mM KCl via micropipette placed close to the myotube 
of interest. See Materials and methods for defi  nitions of 
t  1/2     decay   and r  20  . Asterisks indicate a signifi  cant difference 
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state, the long-duration open state is relatively unpopu-
lated during 200-ms depolarizations to potentials below 
about +50 mV (  Dirksen and Beam, 1996  ). However, en-
try into the long-duration open state does occur during 
longer depolarizations (e.g., as during extended expo-
sure to elevated KCl) and is accelerated by stronger de-
polarizations as well as by exposure to dihydropyridine 
agonists (  Hess et al., 1984  ;   Pietrobon and Hess, 1990  ; 
  Dirksen and Beam, 1996  ). Importantly, the long dura-
tion open state of the wild-type channel preferentially 
allows inward divalent current ( Leuranguer et al., 2003 ). 
Thus, we tested whether strong depolarization in the 
presence of   ±  Bay K 8644 would cause SkEIIIK to enter a 
long-lived open state that would produce inward Ca 
2+   
tail current upon repolarization. 
    Fig. 8 A   compares currents for depolarizations to either 
0 or +80 mV recorded from a dysgenic myotube express-
ing SkEIIIK and bathed in 5   μ  M   ±  Bay K 8644.   The depo-
larization to 0 mV, which is near threshold for activation 
of ionic current, evoked little outward current and re-
sulted in only a small inward current upon the subsequent 
repolarization to     50 mV. However, the depolarization to 
80 mV evoked a robust, slowly activating outward current 
(see peak I-V in Fig. S2) and resulted in an appreciable, 
slowly decaying inward current upon repolarization to 
    50 mV. As shown in   Fig. 8 B  , this slowly decaying inward 
current did not appear to be a consequence of the poten-
tiation by   ±  Bay K 8644 of the endogenous L-type current 
that can be present at low levels in dysgenic myotubes 
(  n   = 14;   I    dys  ) (  Adams and Beam, 1989  ). 
experimental conditions, 40 of 42 normal myotubes 
showed a large, slowly activating Ca 
2+   entry from the ex-
tracellular space in response to global application of 
80 mM KCl (    F/F = 2.11   ±   0.16,   n   = 40;   Fig. 7 A  ).   The pres-
ence of either 100   μ  M Gd 
3+   or 50   μ  M nifedipine, which 
both block the L-type current (  Figs. 1 and 2  ), completely 
eliminated this slow Ca 
2+   entry (  n   = 6 and   n   = 10, respec-
tively;   Fig. 7, B and C  ). In contrast to the robust Ca 
2+   tran-
sients observed in ryanodine-treated normal myotubes, 
no Ca 
2+   transients were detectable (   F/F  <   0.05) in ryano-
dine-treated dysgenic myotubes expressing SkEIIIK (  n   = 
31;   Fig. 7 D  ). Collectively, these results support the idea 
that L-type Ca 
2+   current is a major contributor to Ca 
2+   en-
try in response to prolonged, weak depolarization. 
  The SkEIIIK Pore Mutant Allows Inward Divalent Current 
  Previously, it was reported that in dysgenic myotubes ex-
pressing SkEIIIK, entry of divalent cations in response 
to depolarization could be measured with the indicator 
Fura-2 (  Cherednichenko et al., 2004  ), whereas we were 
unable to detect such entry with the indicator Fluo-3 
(  Figs. 6 and 7  ). Thus, we sought to determine if SkEIIIK 
could permit a small infl   ux of divalent cations that 
might have accounted for the signal measured with 
Fura-2 by   Cherednichenko et al. (2004)  . In this regard, 
it is important to note that L-type Ca 
2+   channels display 
at least two distinct open states of either brief or long 
duration (i.e., Mode 1 and Mode 2 gating, respectively) 
(  Hess et al., 1984  ;   Pietrobon and Hess, 1990  ;   Dirksen 
and Beam, 1996  ). Compared with the short-lived open 
  TABLE III  
  Activation and Decay of Ca 
2+   Transients during Local Depolarizations 
    F/F 
  (    F/F)
t  peak   
  (s)
t  1/2     decay   
  (s)
r  20   
  (%)
normal (2 mM Ca 
2+  ) 3.25   ±   0.35 
  (24)
3.76   ±   0.34 10.64   ±   0.98 31.92   ±   5.03
normal (0 mM Ca 
2+  ) 1.31   ±   0.15   
a     
  (12)
1.97   ±   0.22   
b   4.98    ±   0.45   
a   4.36    ±   2.38   
a   
normal + 100   μ  M Gd 
3+  (2 mM Ca 
2+  ) 1.77   ±   0.18   
b     
  (14)
1.94   ±   0.13   
a   3.49    ±   0.47   
a   2.23    ±   0.74   
a   
dysgenic + SkEIIIK (2 mM Ca 
2+  ) 0.90   ±   0.18   
a     
  (9)
3.51   ±   0.50 4.47   ±   0.52   
a   10.41    ±   2.70   
c   
dysgenic + SkEIIIK (0 mM Ca 
2+  ) 0.25   ±   0.09   
a     
  (5)
2.70   ±   0.45 5.68   ±   1.12   
c   4.97    ±   2.17   
c   
dysgenic (2 mM Ca 
2+  ) no response (12)
dyspedic (2 mM Ca 
2+  ) no response (14)
        1     null (2 mM Ca 
2+  ) no response (10)
dysgenic + SkEIIIK + ryanodine 
  (2 mM Ca 
2+  )
no response (20)
Data presented here were obtained with depolarizations evoked by 20-s applications of 80 mM KCl Ringer  ’  s solution via a micropipette placed near the cell 
of interest. Where indicated, 100   μ  M Gd 
3+   was added to the 80 mM KCl Ringer  ’  s solution in the micropipette. See Materials and methods for defi  nitions 
of t  peak  , t  1/2     decay  , and r  20  . Data are given as mean   ±   SEM, with the numbers in parentheses indicating the number of myotubes tested. Footnotes indicate 
signifi  cant differences compared to normal myotubes in 2 mM Ca 
2+   by unpaired   t test  :
   
a    P   <   0.001.
   
b    P   <   0.005.
   
c    P   <   0.05.    Bannister et al.  87
cated the presence of inward Ca 
2+   current via the mutant 
L-type channel. Thus, these results strongly support the 
hypothesis that SkEIIIK can enter into a long-duration 
  In dysgenic cells expressing SkEIIIK, the presence of 
  ±  Bay K 8644 caused the inward current elicited by repo-
larization from +80 to     50 mV to be both larger and 
more slowly decaying than in the absence of the DHP 
agonist (  Fig. 8 C  ), consistent with the idea that the in-
ward current represents Ca 
2+   infl  ux through channels 
relaxing from the long open state to closed. The total 
charge transported during the inward current elicited 
by repolarization to     50 mV was obtained by integration 
and is plotted in   Fig. 8 D  . The total charge for repolariza-
tion from 0 to     50 mV (3.6   ±   0.7 nC/    F;   n   = 9) was simi-
lar to that previously measured (see Fig. 4 of   Dirksen 
and Beam, 1999  ). This charge was likely to have been 
nonionic and to have arisen from closed  –  closed gating 
transitions of the DHPR because a 200-ms depolariza-
tion to 0 mV activates little ionic conductance via SkEIIIK 
(  Dirksen and Beam, 1999  ). Compared with 0 mV, the to-
tal charge was substantially larger for repolarization from 
+80 to     50 mV (10.5   ±   1.1 nC/    F;   n   = 9). A fraction of 
this additional charge movement (    66% of the total 
300% increase) was also likely to have been nonionic 
and to have arisen from gating transitions that would 
have occurred for repolarization to     50 mV after a 200-
ms depolarization to +80 mV, but not after a 200-ms de-
polarization to 0 mV. Possibly, the remaining portion 
(    33% of the 300% increase) of additional charge 
movement was a consequence of inward Ca 
2+   current 
that resulted from the entry of a small fraction of the 
SkEIIIK channels into the long-duration open state that 
supports such current. In the presence of   ±  Bay K 8644 
(  Fig. 8 D  , gray bars), the total charge after repolarization 
from +80 to     50 mV was so large (33.5   ±   8.0 nC/    F;   n   = 
10) compared with that after repolarization from 0 to 
    50 mV (4.4   ±   1.0 nC/    F;   n   = 10) that it clearly indi-
  Figure 7.     SkEIIIK supports minimal Ca 
2+   entry during long 
global depolarizations. Representative Ca 
2+   transients evoked 
by global perfusion of 80 mM KCl Ringer  ’  s solution for nor-
mal myotubes (A), normal myotubes exposed to 100   μ  M Gd 
3+   
(B), normal myotubes exposed to 50   μ  M nifedipine (C), and 
dysgenic myotubes expressing SkEIIIK (D). In each case, myo-
tubes were exposed to 200   μ  M ryanodine for   >  1 h at 37  °  C 
before experiments to block the contribution of RYR1 to the 
Ca 
2+   transient. In experiments with SkEIIIK, a slower sampling 
rate was used to minimize any bleaching of the Fluo-3 dye. Ex-
pression of SkEIIIK was confi  rmed by electrically evoked (100 V, 
5 ms) contractions (17 of 20 myotubes tested) before ryano-
dine treatment (see   Papadopoulos et al., 2004  ).     
  Figure 8.     Potentiated SkEIIIK conducts inward Ca 
2+   current. 
Representative currents are shown for a   ±  Bay K 8644  –  treated 
(5   μ  M) dysgenic myotube expressing SkEIIIK (A) and a   ±  Bay K 
8644  –  treated, uninjected dysgenic myotube (B). The inset illus-
trates the tail currents shown in A on an expanded time base. 
(C) Summary of amplitudes (left) and deactivation time constants 
(right) of SkEIIIK tail currents recorded in the absence (  n   = 9) 
and presence (  n   = 10) of   ±  Bay K 8644. (D) Total charge moved 
obtained by integration of tail currents recorded in the absence 
(  n   = 9) and presence (  n   = 10) of   ±  Bay K 8644 from dysgenic 
myotubes expressing SkEIIIK. Asterisks indicate signifi  cant dif-
ferences between untreated and   ±  Bay K 8644  –  treated cells (*, P 
  <   0.05; **, P   <   0.01,   t   test).     88   The Skeletal L-type Current Contributes to ECCE 
Mn 
2+   in the absence of bath Ca 
2+   (  Fig. 5  ). During pro-
longed (20-s) KCl depolarization, Ca 
2+   transients in in-
tact, normal myotubes rise to a peak and then decay, 
and this decay is more rapid after the removal of exter-
nal Ca 
2+   or in the presence of Gd 
3+  ; the decay of tran-
sients in dysgenic myotubes expressing the DHPR       1S   
subunit pore mutant (SkEIIIK), which has a low perme-
ability to Ca 
2+  , is similar to that of transients in normal 
myotubes in a Ca 
2+  -free external medium and is little af-
fected by the removal of extracellular Ca 
2+   (  Fig. 6   and 
  Table III  ). Collectively, these results suggest that Ca 
2+   en-
try via the L-type channel slows the decay of Ca 
2+   tran-
sients during prolonged depolarization of normal 
myotubes. After block of SR Ca 
2+   release by pretreatment 
with 200   μ  M ryanodine, depolarization of normal myo-
tubes still resulted in large myoplasmic Ca 
2+   transients, 
whereas depolarization did not elicit a detectable tran-
sient in dysgenic myotubes expressing SkEIIIK (  Fig. 7  ), 
providing strong support to the idea that the L-type 
channel is the predominant source of Ca 
2+   entry. Al-
though SkEIIIK has very low permeability to Ca 
2+  , we 
open state that permits inward divalent cation fl  ux. How-
ever, the similarity of Ca 
2+   transient decay in SkEIIIK-
expressing dysgenic myotubes in 2 mM Ca 
2+   and normal 
myotubes in 0 mM Ca 
2+   (  Fig. 6   and   Table III  ) and the 
lack of detectable SkEIIIK-mediated transients in the 
presence of ryanodine (  Fig. 7 D  ) argues that such a 
mode of Ca 
2+   permeation via SkEIIIK must be quite small 
compared with Ca 
2+   entry via the native L-type channel. 
  DISCUSSION  
  Here, we demonstrate that the skeletal muscle L-type 
Ca 
2+   current and ECCE share many common attributes 
(summarized in   Table IV  ).   Thus, the skeletal muscle 
L-type channel is blocked by nonspecifi  c cation channel 
antagonists (  Fig. 1  ), requires nearly 50   μ  M nifedpine for 
complete channel block (  Fig. 2  ), and is inhibited by 
dantrolene (  Fig. 3  ). We also show that in 2 mM of exter-
nal Ca 
2+  , the L-type Ca 
2+   current, like ECCE, is persisten-
tly activated by weak voltage steps (  Fig. 4  ). In addition, 
we demonstrate that the L-type channel is permeable to 
  TABLE IV  
  Common attributes of ECCE and the skeletal muscle L-type current 
ECCE I  L 
Is voltage-dependent yes   
a     
,     
b   yes   
c     
,     
d     
,     
e   
Conducts Ca 
2+ yes   
a     
,     
b     
,     
c     
,     
f   yes   
c     
,     
d     
,     
e   
Requires       1S   subunit yes   
a     
,     
b     
,     
e   yes   
c     
,     
d   
Requires       1a   subunit yes   
e   increased  expression   
g     
,     
h     
,     
i     
,     
j   
Reduced by siRNA against       2        1   subunit yes   
k   faster  inactivation   
k     
,     
l   
Requires RYR1 yes   
a     
,     
b     
,     
e     
,     
f   greatly  potentiated   
m     
,     
n   
Blocked by 100   μ  M La 
3+ substantial   
o   complete   
e   
Blocked by 100   μ  M Gd 
3+ complete   
a     
,     
p     
,     
e   complete   
e   
Blocked by 20   μ  M SKF 96356 complete   
a     
,     
b     
,     
o   complete   
e   
Blocked by 100   μ  M 2-APB     80%   
a     
,     
b       80%   
e   
Blocked by 1   μ  M nifedipine incomplete   
o   incomplete   
e   
Blocked by 50   μ  M nifedipine complete   
e   complete   
e   
Reduced by   ≥  10   μ  M dantrolene partial   
e     
,     
q   modest   
e     
,     
r   
Conducts Mn 
2+ yes   
a     
,     
b     
,     
f     
,     
k     
,     
q   yes   
e   
Divalent entry via SkEIIIK yes   
a   yes   
e   
Mediated by Orai1/STIM1 no   
f   no   
c     
,     
d   
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the slow L-type current from SOCE, which functions nor-
mally in dysgenic and dyspedic myotubes ( Cherednichenko 
et al., 2004  ;   Hurne et al., 2005  ; but see   Lyfenko and 
Dirksen, 2008  ). Another parallel between ECCE and 
the slow L-type Ca 
2+   current is that myotubes null for the 
DHPR       1a   subunit lack ECCE (  Table III  ) and have 
greatly reduced expression of L-type current (  Gregg 
et al., 1996  ;   Strube et al., 1996  ;   Papadopoulos et al., 
2004  ;   Sheridan et al., 2004  ). Interestingly, knockdown 
of the DHPR       2        1   subunit in myotubes by siRNA causes 
a reduction in ECCE (  Gach et al., 2008  ) and an acceler-
ated inactivation of the L-type Ca 
2+   current measured 
with 200-ms depolarizations (  Obermair et al., 2005  ; 
  Gach et al., 2008  ;   Obermair et al., 2008  ). During pro-
longed depolarizations, the accelerated inactivation might 
greatly reduce Ca 
2+   entry via the L-type channel. 
  Previously,   Hurne et al. (2005)   attempted unsuccess-
fully to measure a current associated with ECCE by the 
application of 6-s test pulses to     20 mV. In retrospect, 
this result is consistent with the hypothesis that the 
L-type Ca 
2+   current is a major contributor to the ECCE 
signal because depolarizations to     20 mV would not 
have activated L-type current in 10 mM of extracellular 
Ca 
2+   (  Fig. 4 A  ), as used in the measurements of   Hurne 
et al. (2005)  . In 2 mM Ca 
2+  , however, the leftward shift 
of activation has the result that long (    10-s) depolariza-
tions to     10 or 0 mV evoke sustained L-type currents 
(  Fig. 4 B  ) that would support substantial Ca 
2+   entry un-
der the conditions used for measuring ECCE. In addi-
tion, relatively weak depolarizations activate currents 
carried by Mn 
2+   in the absence of external Ca 
2+   (  Fig. 5  ), 
which means that the L-type channel would produce 
Mn 
2+   entry under the conditions used to measure Mn 
2+   
quench attributed to ECCE (  Table IV  ). 
  During prolonged depolarization of normal myo-
tubes, the entry of Ca 
2+   appears to slow the decay of 
the myoplasmic Ca 
2+   transient inasmuch as removal of 
external Ca 
2+   causes the decay to become more rapid 
(  Fig. 6  ). This same manipulation does not greatly affect 
the time course of transients in dysgenic myotubes 
expressing SkEIIIK, which decay much like those of 
normal myotubes in a Ca 
2+  -free medium. In principle, 
removing extracellular Ca 
2+   could not only have elimi-
nated Ca 
2+   entry, but also increased inactivation of the 
voltage sensor for EC coupling (  Brum et al., 1988a,b  ). 
Indeed, the amplitude of the Ca 
2+   transients in Ca 
2+  -free 
medium was smaller for both normal myotubes and dys-
genic myotubes expressing SkEIIIK (  Table III  ), consis-
tent with the possibility that removal of Ca 
2+   increased 
steady-state inactivation of voltage sensors in resting 
myotubes.   Cherednichenko et al. (2004)   also observed 
a similar reduction of the KCl-evoked Ca 
2+   transient in a 
Ca 
2+  -free medium. However, altered inactivation during 
the KCl application does not seem to have been a major 
factor in causing more rapid decay because: (1) an ac-
celeration of decay like that seen with Ca 
2+   removal was 
did fi  nd that after strong depolarization in the presence 
of   ±  Bay K 8644, the channel could conduct inward Ca 
2+   
tail currents upon repolarization (  Fig. 8  ). 
  One very clear conclusion from our results is that any 
of the manipulations that have been used to evaluate the 
magnitude of ECCE will necessarily produce changes in 
current via the L-type Ca 
2+   channel (  Table IV  ) and thus 
the contribution of the L-type current to the myoplas-
mic Ca 
2+   transient. For example, the addition of Gd 
3+  , 
20   μ  M SKF 96356, and 100   μ  M 2-APB and the removal of 
external Ca 
2+   block 80 –  100% of ECCE ( Cherednichenko 
et al., 2004  ;   Hurne et al., 2005  ), and we fi  nd they also 
block L-type Ca 
2+   current to a similar extent. Conversely, 
the relative insensitivity of ECCE to 1   μ  M nifedipine has 
been taken as an indication that it is independent of 
L-type current (  Yang et al., 2007  ). In particular,   Yang et al. 
(2007)   reported that 1   μ  M nifedipine causes only a 5% 
decrease in the decay of the sustained phase of the KCl-
evoked transient for wild-type RYR1 (Fig. 6 B of   Yang 
et al., 2007  ), whereas 100   μ  M La 
3+   causes a 14% decrease 
(Fig. 4 B of   Yang et al., 2007  ). If it is assumed that the al-
tered decay rate for 100   μ  M La 
3+   refl  ected a complete 
block of ECCE, then 1   μ  M nifedipine caused a 36% 
block, close to the     50% block of L-type current that we 
found for 1   μ  M nifedipine (  Fig. 2 D  ). 
  We found that maximal L-type Ca 
2+   currents in myo-
tubes were reduced     15% by 10   μ  M dantrolene (  Fig. 3  ), 
a similar fi  nding to that of   Szentesi et al. (2001)  , who ob-
served that L-type currents are reduced     25% in adult 
rodent fi  bers by 25   μ  M dantrolene. These electrophysio-
logical results are in good agreement with the observa-
tion that Ca 
2+   transients evoked by 40 mM KCl were 
reduced     20% in 10   μ  M of dantrolene-pretreated myo-
tubes compared with matched control myotubes (Fig. S3). 
However, an earlier report indicated that 10   μ  M dan-
trolene caused a more substantial (    65%) reduc      tion 
in quench of Fura-2 fl  uorescence by Mn 
2+   entry in 
response to 40 mM KCl or electrical stimulation 
(  Cherednichenko et al., 2008  ). In evaluating the differ-
ence in dantrolene sensitivity found in the two sets of ex-
periments, it should be noted that the response of the 
fl  uorescent indicator (Fluo-3 to Ca 
2+  , Fura-2 to Mn 
2+  ) de-
pends not only on the magnitude of the entry fl  ux, but also 
on the divalent affi  nity of the indicator and on the buffer-
ing and removal of the divalent cations that have entered 
the myoplasm. Consequently, the change in fl  uorescence 
might well not depend linearly on the entry fl  ux, making 
it diffi  cult to directly compare these measurements. 
  The dependence of ECCE on the presence of both 
the DHPR       1S   subunit and RYR1 (  Cherednichenko 
et al., 2004 ;  Hurne et al., 2005 ;  Lyfenko and Dirksen, 2008 ) 
is also a feature of the slow L-type Ca 
2+   current, which is 
totally absent in dysgenic muscle cells lacking       1S   (  Beam 
et al., 1986  ;   Tanabe et al., 1988  ), and greatly reduced in 
dyspedic muscle cells lacking RYR1 (  Nakai et al., 1996  ; 
  Avila and Dirksen, 2000  ). This distinguishes ECCE and 90   The Skeletal L-type Current Contributes to ECCE 
perhaps sole) component of ECCE. Previously, the Ca 
2+   
entry ascribed to ECCE was shown to help maintain 
myoplasmic Ca 
2+   levels during either sustained depolar-
izations or during trains of repetitive brief stimuli 
(  Cherednichenko et al., 2008  ;   Gach et al., 2008  ). It now 
appears that this role can be reassigned to the L-type 
Ca 
2+   current and perhaps represents one of its physio-
logical functions in skeletal muscle. 
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